Amgen’s Imdelltra combo cuts risk of death by 58% in lung cancer
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama…
Moderna, Merck’s cancer vaccine data a major advancement
Leaked confidential data. A major stock sell-off. Beneath the chaos surrounding Moderna and Merck‘s latest data on their…
Eli Lilly obesity drug with amylin, tirzepatide boosts weight loss in trial
Eli Lilly on Wednesday said its experimental combination regimen showed greater weight loss than a high dose of…
Ozempic counterfeit ring charges against Indian nationals unsealed
Two Indian nationals have been charged in federal court in Florida with an alleged conspiracy to smuggle counterfeit…
Why is the blood pressure drug chlorthalidone being recalled?
Thousands of bottles of a popular blood pressure medication are being recalled over concerns about effectiveness. Inventia Healthcare…
Novartis trial failure raises stakes for Amgen and Eli Lilly in Lp(a) drug race
Blood sample for a lipoprotein(a) test. Md Babul Hosen | Istock | Getty Images Novartis‘ failure in a…
Trump strikes new drug pricing deals with nine midsized drugmakers
U.S. President Donald Trump delivers remarks on his administration’s healthcare policies, in the Oval Office at the White…
FDA approves Rasonque, pancreatic cancer drug expected to extend lives
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
New clues emerge in direction of RFK Jr.’s vaccine policy changes
WASHINGTON — President Trump and health secretary Robert F. Kennedy Jr. are pressing ahead with efforts to change…
Moderna, Merck cancer vaccine shows initial late-stage melanoma data
An experimental personalized cancer vaccine from Merck and Moderna showed positive initial results in its first-ever late-stage trial,…
MMR vaccine: Trump wants to split childhood shot up
President Donald Trump‘s latest executive order calls for splitting the measles, mumps and rubella, or MMR, vaccine into…
FDA clears Replimune melanoma drug RP1 for continued testing
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…